1. Home
  2. CCG vs ICCC Comparison

CCG vs ICCC Comparison

Compare CCG & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CCG

Cheche Group Inc.

N/A

Current Price

$0.79

Market Cap

66.5M

Sector

N/A

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$6.11

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCG
ICCC
Founded
2014
1982
Country
China
United States
Employees
548
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.5M
55.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
CCG
ICCC
Price
$0.79
$6.11
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$350.00
N/A
AVG Volume (30 Days)
60.6K
12.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.33
EPS
N/A
0.20
Revenue
N/A
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
$15.80
N/A
P/E Ratio
N/A
$30.30
Revenue Growth
N/A
51.64
52 Week Low
$0.72
$4.52
52 Week High
$1.54
$7.60

Technical Indicators

Market Signals
Indicator
CCG
ICCC
Relative Strength Index (RSI) 51.04 38.92
Support Level $0.74 $5.72
Resistance Level $0.82 $6.90
Average True Range (ATR) 0.02 0.24
MACD 0.00 -0.04
Stochastic Oscillator 74.83 7.14

Price Performance

Historical Comparison
CCG
ICCC

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: